Best Manufacturer Of Astragaloside IV CAS NO (84687-43-4) In low price

Title: Astragaloside IV (84687-43-4): Pharmacological Activities, Mechanisms of Action, and Therapeutic Potential

1. Introduction to Astragaloside IV (84687-43-4)

   • Astragaloside IV is a bioactive compound derived from the root of Astragalus membranaceus, a traditional Chinese medicinal herb.
   • This review explores the pharmacological activities, mechanisms of action, and therapeutic potential of astragaloside IV.

2. Chemical Structure and Sources

   • Astragaloside IV is a cycloartane-type triterpene saponin characterized by its unique chemical structure, comprising a cycloartane skeleton with sugar moieties attached.
   • It is isolated from the root of Astragalus membranaceus and other Astragalus species, commonly known as Huangqi in traditional Chinese medicine.

3. Pharmacological Activities

   • Astragaloside IV exhibits a wide range of pharmacological activities, including anti-inflammatory, immunomodulatory, anti-oxidant, anti-cancer, cardioprotective, and neuroprotective effects.
   • Its multifaceted biological properties make it a valuable compound for the prevention and treatment of various diseases and disorders.

4. Anti-Inflammatory Activity

   • Astragaloside IV exerts anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines, such as TNF-α, IL-1β, and IL-6.
   • It suppresses the activation of NF-κB and MAPK signaling pathways, attenuating inflammation in various tissues and organs.

5. Immunomodulatory Effects

   • Astragaloside IV modulates immune responses by enhancing the activity of immune cells, such as T cells, B cells, macrophages, and natural killer (NK) cells.
   • It stimulates the production of cytokines and antibodies, promoting immune surveillance and defense against pathogens and tumor cells.

6. Anti-Oxidant Properties

   • Astragaloside IV possesses potent anti-oxidant properties, scavenging free radicals and reactive oxygen species (ROS) and protecting cells from oxidative damage.
   • It enhances endogenous antioxidant defense mechanisms and reduces oxidative stress-related pathologies in various tissues and organs.

7. Anti-Cancer Activity

   • Astragaloside IV shows anti-cancer activity against various types of cancers, including lung, breast, colon, and liver cancers.
   • It inhibits tumor cell proliferation, induces apoptosis, suppresses angiogenesis, and inhibits metastasis by modulating multiple signaling pathways involved in carcinogenesis.

8. Cardioprotective Effects

   • Astragaloside IV confers cardioprotective effects by improving cardiac function, reducing myocardial injury, and ameliorating cardiac remodeling.
   • It regulates lipid metabolism, reduces oxidative stress, and inhibits inflammatory responses in the cardiovascular system, protecting against atherosclerosis, hypertension, and heart failure.

9. Neuroprotective Properties

   • Astragaloside IV possesses neuroprotective effects by attenuating neuroinflammation, oxidative stress, and neuronal damage.
   • It enhances neuronal survival, synaptic plasticity, and cognitive function, offering potential therapeutic benefits in neurodegenerative disorders such as Alzheimer's and Parkinson's diseases.

10. Conclusion: Therapeutic Potential of Astragaloside IV

    • Astragaloside IV, a bioactive compound derived from Astragalus membranaceus, exhibits diverse pharmacological properties with therapeutic implications for the prevention and treatment of inflammatory diseases, cancer, cardiovascular disorders, neurodegenerative conditions, and immune-related disorders.
    • Further research is needed to elucidate its mechanisms of action, optimize its pharmacokinetic properties, and evaluate its efficacy and safety in clinical trials for the development of novel therapeutic agents.